Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Mediated Disease: The Difficulty of Predicting Relapses

被引：0
|
作者：
Epstein, S. [1 ]
Levin, S. N. [1 ]
Onomichi, K. [2 ]
Langston, C. [3 ]
Yeshokumar, A. [4 ]
Dykstra, K. [5 ]
Xia, Z. [6 ]
Levine, L. [2 ]
De Jager, P. L. [2 ]
Farber, R. [2 ]
Riley, C. S. [2 ]
Vargas, W. S. [2 ]
机构：
[1] Columbia Univ, Irving Med Ctr, Neurol, New York, NY USA
[2] Columbia Univ, Irving Med Ctr, New York, NY USA
[3] Mt Sinai Hosp, Neurol, New York, NY 10029 USA
[4] Mt Sinai Hosp, Pediat Neurol, New York, NY 10029 USA
[5] Univ Pittsburgh, Med Ctr, Neurol, Pittsburgh, PA USA
[6] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P142
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [1] Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses
    Epstein, Samantha E.
    Levin, Seth
    Onomichi, Kaho
    Langston, Christopher
    Yeshokumar, Anusha
    Fabian, Michelle
    Sand, Ilana Katz
    Klineova, Sylvia
    Lublin, Fred
    Dykstra, Kiersten
    Xia, Zongqi
    De Jager, Philip
    Levine, Libby
    Farber, Rebecca
    Riley, Claire
    Vargas, Wendy S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [2] Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease and MOG Testing Landscape in Canada
    Burton, Jodie
    Youn, Saerom
    Al-Ani, Abdullah
    Costello, Fiona
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 409 - 410
  • [3] The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis
    Stefferl, A
    Brehm, U
    Linington, C
    ADVANCES IN RESEARCH ON NEURODEGENERATION, VOL 7, 2000, 7 : 123 - 133
  • [4] The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis
    Stefferl, A
    Brehm, U
    Linington, C
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2000, (58): : 123 - 133
  • [5] Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations
    Jurynczyk, Maciej
    Jacob, Anu
    Fujihara, Kazuo
    Palace, Jacqueline
    PRACTICAL NEUROLOGY, 2019, 19 (03) : 187 - 195
  • [6] Unique presentations of myelin oligodendrocyte glycoprotein antibody (MOG) associated demyelinating disease
    Pujari, S.
    Kulkarni, R.
    Ojha, P.
    Nadgir, D.
    Nadgir, R.
    Nagendra, S.
    Aglave, V.
    Bandishti, S.
    Kulkarni, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 901 - 902
  • [7] Urogenital dysfunction in myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
    Li, V.
    Da Silva Leite, M.
    Messina, S.
    Everett, R.
    Panicker, J.
    Palace, J.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 146 - 146
  • [8] Myelin Oligodendrocyte Glycoprotein Antibody-mediated Cervical Myelitis Presenting As Radicular Headache
    Krett, J. D.
    Alikhani, K.
    Jarvis, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 108 - 108
  • [9] AZD-1222Myelin oligodendrocyte glycoprotein antibody-mediated optic neuritis
    Reactions Weekly, 2024, 1992 (1) : 43 - 43
  • [10] Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
    Akaishi, Tetsuya
    Konno, Masatoshi
    Nakashima, Ichiro
    Aoki, Masashi
    INTERNAL MEDICINE, 2016, 55 (19) : 2905 - 2906
12345